Escolar Documentos
Profissional Documentos
Cultura Documentos
kanser
DR NIK ROSMAWATI NIK HUSAIN
PAYUDARA
KONSEP KANSER /BARAH
cells change and grow out of control
Most cancer cells form a lump or mass called a tumor, and are
named after the part of the body where the tumor first starts
Most tumors in the breast are benign; that is, they are not
cancer at all, abnormal growths, but they do not grow and
spread, and are not life threatening
Some breast tumors are cancerous, but are called in situ,
confined within the ducts or lobules, majority will not progress to
become an invasive tumor, and at this early stage nearly all of
these cancers can be cured.
Other cancerous breast tumors are invasive, or infiltrating
local stage; confined to the breast;
regional stage; spread to the lymph nodes;
distant stage; metastasized (spread to distant sites).
Breast Anatomy
Breast profile:
A ducts
B lobules
C dilated section of duct to hold milk
D nipple
Lymph node areas adjacent to breast area.
E fat
A pectoralis major muscle
F pectoralis major muscle
B axillary lymph nodes: levels I
G chest wall/rib cage
C axillary lymph nodes: levels II
D axillary lymph nodes: levels III
Enlargement:
E supraclavicular lymph nodes
A normal duct cells
F internal mammary lymph nodes
B basement membrane
C lumen (center of duct
Range of Ductal Vascular and
Carcinoma in situ (DCIS) Lymphatic Invasion
Epidemiology of Breast Ca -
WORLDWIDE
most common cancer among women,
nearly one of every three cancers
diagnosed in American women
> than 1 million cases annually
(IR=>80/10,000)
2nd leading cause of death by Ca in
women (1% occur in male)
Incidence is high in developed country
(US,UK<Australia), but mortality rate is
low there compare to the developing
countries
There is a marked geographical diff due
to genetic, lifestyle and environ
Epidemiology of Breast Ca - WORLDWIDE
Epidemiology of Breast Ca - WORLDWIDE
Epidemiology of Breast Ca - MALAYSIA
3. Systemic Therapy
a) chemotherapy [cyclophosphamide, methotrexate, fluorouracil,
doxorubicin (adriamycin), epirubicin, and paclitaxel (taxol)]
Adjuvant systemic therapy is used after all visible cancer has been
surgically removed in order to kill any undetected tumor cells that
may have migrated to other parts of the body - reducing rates of
recurrence and death that persist more than 15 years after
treatment.
treating women with advanced breast cancer
b) hormone therapy - Tamoxifen
Lumpectomy